SCHEMBL5163926

SCHEMBL5163926

CSc1cccc(NCc2n[nH]c(=O)c3ccccc23)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ KMT2A Q03164 4/20 0.58
▸ GAA P10253 2/20 0.58
▸ HTT P42858 2/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ THRB P10828 1/20 0.58
▸ RECQL P46063 1/20 0.58
▸ BLM P54132 1/20 0.58
▸ HIF1A Q16665 1/20 0.52
▸ LMNA P02545 1/20 0.51
▸ PARP1 P09874 5/20 0.48
▸ AR P10275 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ PRMT5 O14744 1/20 0.46
▸ BRD4 O60885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165966 0.81 MAPT (0.78) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5163003 0.78 MAPT (1.00) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5160111 0.74 MAPT (0.75) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5160240 0.74 MAPT (1.00) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5161752 0.73 MAPT (1.00) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5159968 0.73 KMT2A (0.58) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL22964292 0.72 MEN1 (0.67) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL5164835 0.71 MAPT (0.77) MAPTSMN1; SMN2KMT2AGAAHTT
SCHEMBL30231202 0.70 PRMT5 (0.68) SMN1; SMN2ALDH1A1LMNAPARP1AR
SCHEMBL7462930 0.70 PRMT5 (0.68) SMN1; SMN2ALDH1A1LMNAPARP1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1231982-B1 USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ABBOTT GMBH & CO KG (DE) 2007-03-21 — — EP disclosed
US-6903098-B1 Use of phthalazine derivatives ABBOTT GMBH & CO. (DE) 2005-06-07 — — US disclosed
EP-1231982-A2 USE OF PHTHALAZINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2002-08-21 — — EP disclosed
WO-2001082877-A2 USE OF PARP INHIBITORS IN COSMETIC PREPARATIONS BASF AKTIENGESELLSCHAFT (DE) 2001-11-08 — — WO disclosed
WO-2000067734-A2 USE OF PHTHALAZINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-11-16 — — WO disclosed
Send feedback